BridgeMD
New treatment option for Hypertension
Official title The REACH-OUT Trial
ClinicalTrials.gov ID: NCT07540143
What this study is testing
- What it's testing
- Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 44, women only
You may be able to join if
- biologically female
- age 18-44
- English or Spanish-speaking
- prescribed an antiHTN
- have a systolic BP \>140 or diastolic BP\>90 at their index visit
You likely can't join if
- not pregnant or within 3 months postpartum
- severe, uncorrectable vision, hearing, or cognitive impairment that would preclude study consent or participation
See the full eligibility criteria
- biologically female
- age 18-44
- English or Spanish-speaking
- prescribed an antiHTN
- have a systolic BP \>140 or diastolic BP\>90 at their index visit
- have access to the internet
- not pregnant or within 3 months postpartum
- severe, uncorrectable vision, hearing, or cognitive impairment that would preclude study consent or participation
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years to 44 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.